Infrastructure

Manufacturing wide range of quality products that improves lives

We have invested to establish the state-of-the-art manufacturing facilities meeting global pharma standards. It is spread over an area of 6 acres and will be engaged in production of Oncology and Critical Care molecules. The manufacturing facilities are approvable by major global regulatory agencies including the USFDA, MHRA, EMA, TGA, MCC, ANVISA and more.

Proposed manufacturing facility

  • Acquired 5.625 acres of land at Genome Valley, Shamirpet, Hyderabad for setting up of manufacturing facility
  • To construct dedicated blocks for Manufacturing, Utilities and Administration
  • To setup following manufacturing lines:

Critical Care

  • Lyophilized vials
  • Liquid vials
  • Liquid ampoules
  • Pre-filled syringe
  • Dry powder vials

Research and Development

  • In-house R&D Centre at Biotech Park, Genome Valley, Shamirpet, Hyderabad spread over 11,500 sq. ft.
  • A 45 member team with:
  • 12 Formulations R&D scientists;
  • 19 Analytical R&D scientists;
  • 1 IPR;
  • 2 Development QA team;
  • 8 admin staff; and
  • 3 support function.

R & D Capabilities

  • The team has the capability to develop molecules in critical care and other therapies of any nature (complex, differentiated, lyophilized, terminally sterilised), like –

–  Microspheres formulations

–  In-situ depot formulations

–  Liposomal formulations

–  Nano-suspension or nano-particulate formulation

–  Micellar formulations

–  Self-micro emulsifying drug delivery system (SMEDS)

–  Micro or nano emulsion

 
  • The R&D team can churn out about 30 products in a year

Vivint Pharma Pvt. ltd.

Corporate Office:  Sirisuns Hirise Building, First & Second Floor, Plot No.13, Sy. No. 70, Image Garden Road, Silicon Valley, Madhapur, Hyderabad-500081

FOR ENQUIRIES

CONTACT

Vivint-Logo
Linkedin Twitter Youtube

Vivint Pharma Pvt. Ltd. © 2024 | All Rights Reserved | Powered by Dhatri